NBE-Therapeutics

NBE-Therapeutics

Verified
Research in cancer treatment.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$1.3b (Public information from Dec 2020)
Company register number CH-270.4.003.576-2
Basel Canton of Basel-Stadt (HQ)

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR2015201620172018
Revenues0000000000000000
% growth-1 %(8 %)4 %
EBITDA0000000000000000
Profit0000000000000000
EV / revenue00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x
R&D budget0000000000000000

Source: Dealroom estimates

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

$0.0

round
investor

$0.0

round
investor

$0.0

round
investor investor

$0.0

round
investor investor investor

$0.0

round
investor investor investor

$0.0

round

€1.2b

Valuation: €1.2b

Acquisition
Total Funding000k

Recent News about NBE-Therapeutics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo